INS and Hypoglycemia: The importance of residual insulin secretion was already highlighted in the DCCT study (Diabetes Control and Complications Trial) in which participants with stimulated C-peptide higher than 200 nmol/L had better glycemic control, lower risk of hypoglycemia and lower risk of diabetes chronic complications [2, 3].